Departments, Centers, & Programs:
55 Fruit Street
Boston, MA 02114-2696
- MD, Stanford University School of Medicine
- Residency, Beth Israel Deaconess Medical Center
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Anatomic Pathology & Clinical Pathology, American Board of Pathology
- Pathology, American Board of Pathology
Dr. Harris's research has focused on the relationship of lymphoid neoplasms to the normal immune system. Her studies range from investigations of the biology and pathology of Hodgkin's lymphoma to the study of nodal and extranodal small B-cell lymphomas, including follicular, mantle cell and MALT lymphomas, to the study of large B-cell lymphomas in the mediastinum and in specific extranodal sites. Having learned hematopathology in an age of multiple classifications of lymphomas, Dr. Harris became particularly interested in establishing consensus in the classification of lymphoid neoplasms.
Working first with the International Lymphoma Study Group and then with the World Health Organization, Dr. Harris and colleagues formulated the Revised European American Classification of Lymphoid Neoplasms (REAL) and in 2001, published a new WHO Classification of lymphoid and myeloid neoplasms. This classification represents the first true international consensus on the classification of hematologic neoplasms, and established a paradigm for arriving at consensus among pathologists and clinicians on disease classification. An update was published in 2008.
In organizing and editing the Clinicopathologic Conferences at Massachusetts General Hospital, which are published as the Case Records of the Massachusetts General Hospital in the New England Journal of Medicine, Dr. Harris has taken on the responsibility for educating readers about the contributions of pathologists, both laboratory medicine and anatomic pathologists, to the diagnosis and management of disease.
For a list of co-authors, related research concepts, and a timeline, visit Dr. Harris' profile page at the Harvard Clinical and Translational Science Center.